With a promising new plan to pay for pricey cures, two states set out to eliminate hepatitis C. But cost hasn’t been the biggest problem

Both states had good plans, argued Sonia Canzater, the associate director of the Hepatitis Policy Project at Georgetown University. They just didn’t have the full support necessary to actually implement those plans.

Read more here.